Best Stocks Under $5 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Ur Energy NYSEAMERICAN:URG$1.50 -0.05 (-3.23%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$1.52 +0.02 (+1.67%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$615.86 millionConsensus RatingBuyConsensus Price Target$2.57 (+71.1% Upside)Volume47.05 million sharesAverage Volume12.21 million sharesToday's Range$1.45▼$1.62 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Curaleaf OTCMKTS:CURLF$3.64 0.00 (0.00%) As of 06/4/2026Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about CuraleafMarket Capitalization$2.54 billionConsensus RatingBuyVolume1.32 million sharesAverage Volume1.24 million sharesToday's Range$3.33▼$3.8350-Day Range$3.64▼$11.973. Aclaris Therapeutics NASDAQ:ACRS$4.50 +0.08 (+1.81%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.31 -0.19 (-4.20%) As of 06/18/2026 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$617.31 millionConsensus RatingBuyConsensus Price Target$11.50 (+155.6% Upside)Volume4.32 million sharesAverage Volume1.06 million sharesToday's Range$4.36▼$4.584. iBio NASDAQ:IBIO$1.69 +0.09 (+5.63%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.68 0.00 (-0.30%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$79.49 millionConsensus RatingBuyConsensus Price Target$5.00 (+195.9% Upside)Volume911,548 sharesAverage Volume808,214 sharesToday's Range$1.61▼$1.735. Inhibikase Therapeutics NASDAQ:IKT$1.83 +0.15 (+8.93%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.82 -0.01 (-0.27%) As of 06/18/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase TherapeuticsMarket Capitalization$221.82 millionConsensus RatingBuyConsensus Price Target$5.40 (+195.1% Upside)Volume1.48 million sharesAverage Volume533,966 sharesToday's Range$1.71▼$1.836. Perspective Therapeutics NYSEAMERICAN:CATX$2.95 -0.03 (-1.01%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$2.97 +0.02 (+0.68%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective TherapeuticsMarket Capitalization$339.86 millionConsensus RatingBuyConsensus Price Target$12.63 (+328.0% Upside)Volume7.66 million sharesAverage Volume1.34 million sharesToday's Range$2.93▼$3.137. Inventiva NASDAQ:IVA$3.57 +0.04 (+1.13%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$3.62 +0.05 (+1.34%) As of 06/18/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about InventivaMarket Capitalization$733.21 millionConsensus RatingBuyConsensus Price Target$16.56 (+363.7% Upside)Volume3.55 million sharesAverage Volume682,287 sharesToday's Range$3.53▼$3.618. Larimar Therapeutics NASDAQ:LRMR$3.64 +0.10 (+2.77%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$3.54 -0.09 (-2.56%) As of 06/18/2026 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar TherapeuticsMarket Capitalization$367.75 millionConsensus RatingBuyConsensus Price Target$15.29 (+320.2% Upside)Volume3.30 million sharesAverage Volume1.70 million sharesToday's Range$3.49▼$3.769. DiDi Global OTCMKTS:DIDIY$3.50 -0.07 (-1.96%) As of 06/18/2026 04:00 PM EasternDiDi Global Inc operates a mobility technology platform that provides ride hailing and other services in the People's Republic of China, Brazil, Mexico, and internationally. More about DiDi GlobalMarket Capitalization$16.27 billionConsensus RatingBuyConsensus Price Target$8.60 (+145.7% Upside)Volume9.27 million sharesAverage Volume7.71 million sharesToday's Range$3.48▼$3.5610. Aquestive Therapeutics NASDAQ:AQST$4.70 +0.27 (+5.98%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$4.64 -0.06 (-1.17%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive TherapeuticsMarket Capitalization$555.74 millionConsensus RatingBuyConsensus Price Target$8.50 (+81.0% Upside)Volume3.02 million sharesAverage Volume1.38 million sharesToday's Range$4.45▼$4.7411. Standard Lithium NYSEAMERICAN:SLI$3.41 -0.08 (-2.29%) As of 06/18/2026 04:10 PM EasternStandard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. More about Standard LithiumMarket Capitalization$850.36 millionConsensus RatingBuyConsensus Price Target$5.13 (+50.3% Upside)Volume5.20 million sharesAverage Volume1.60 million sharesToday's Range$3.37▼$3.5712. Achieve Life Sciences NASDAQ:ACHV$4.85 -0.51 (-9.51%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.90 +0.05 (+1.03%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life SciencesMarket Capitalization$550.25 millionConsensus RatingBuyConsensus Price Target$14.67 (+202.4% Upside)Volume6.94 million sharesAverage Volume1.33 million sharesToday's Range$4.82▼$5.5013. StorageVault Canada OTCMKTS:SVAUF$3.36 0.00 (0.00%) As of 06/17/2026 01:14 PM EasternStorageVault Canada Inc owns, manages, and rents self-storage and portable storage space to individual and commercial customers in Canada. More about StorageVault CanadaConsensus RatingBuyVolume31,272 sharesAverage Volume28,643 sharesToday's Range$3.36▼$3.3650-Day Range$3.00▼$3.4152-Week Range$2.66▼$3.7814. Peraso NASDAQ:PRSO$0.91 +0.02 (+1.95%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.90 0.00 (-0.51%) As of 06/18/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about PerasoMarket Capitalization$13.12 millionConsensus RatingBuyConsensus Price Target$3.00 (+230.5% Upside)Volume468,160 sharesAverage Volume691,817 sharesToday's Range$0.90▼$0.9215. Trilogy Metals NYSEAMERICAN:TMQ$3.79 0.00 (0.00%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$3.80 +0.02 (+0.40%) As of 06/18/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Trilogy Metals Inc, a base metals exploration company, engages in the exploration and development of mineral properties in the United States. More about Trilogy MetalsMarket Capitalization$653.95 millionConsensus RatingBuyConsensus Price Target$7.75 (+104.5% Upside)Volume2.39 million sharesAverage Volume2.40 million sharesToday's Range$3.69▼$3.8916. Cybin NASDAQ:HELP$4.67 +0.09 (+1.97%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.70 +0.04 (+0.75%) As of 06/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cybin Inc, a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a discovery-phase phenethylamine derivative to treat neuroinflammation and psychiatric conditions. More about CybinMarket Capitalization$236.47 millionConsensus RatingBuyConsensus Price Target$58.75 (+1,158.0% Upside)Volume455,144 sharesAverage Volume578,760 sharesToday's Range$4.45▼$4.7617. Adagene NASDAQ:ADAG$3.94 +0.41 (+11.61%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.03 +0.09 (+2.28%) As of 06/18/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Adagene Inc, a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers. More about AdageneMarket Capitalization$167.27 millionConsensus RatingBuyConsensus Price Target$8.00 (+103.0% Upside)Volume164,944 sharesAverage Volume184,115 sharesToday's Range$3.57▼$4.0218. Stereotaxis NYSEAMERICAN:STXS$1.88 +0.10 (+5.62%) Closing price 06/18/2026 04:10 PM EasternExtended Trading$1.88 +0.01 (+0.27%) As of 06/18/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about StereotaxisMarket Capitalization$173.97 millionConsensus RatingBuyConsensus Price Target$3.88 (+106.1% Upside)Volume814,264 sharesAverage Volume328,680 sharesToday's Range$1.77▼$1.9119. Verastem NASDAQ:VSTM$4.12 -0.05 (-1.20%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.13 +0.01 (+0.27%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Verastem, Inc, a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. More about VerastemMarket Capitalization$366.43 millionConsensus RatingModerate BuyConsensus Price Target$15.60 (+278.6% Upside)Volume4.77 million sharesAverage Volume2.24 million sharesToday's Range$4.11▼$4.4320. Atai Beckley NASDAQ:ATAI$4.06 -0.01 (-0.25%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.08 +0.02 (+0.49%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Atai Beckley N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about Atai BeckleyMarket Capitalization$1.50 billionConsensus RatingModerate BuyConsensus Price Target$16.00 (+294.1% Upside)Volume6.62 million sharesAverage Volume5.11 million sharesToday's Range$4.00▼$4.2221. CytomX Therapeutics NASDAQ:CTMX$2.95 -0.01 (-0.34%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$2.98 +0.03 (+0.88%) As of 06/18/2026 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX TherapeuticsMarket Capitalization$503.75 millionConsensus RatingModerate BuyConsensus Price Target$12.10 (+310.2% Upside)Volume9.73 million sharesAverage Volume3.57 million sharesToday's Range$2.89▼$3.0722. Grab NASDAQ:GRAB$3.57 +0.12 (+3.48%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$3.58 +0.01 (+0.14%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. More about GrabMarket Capitalization$14.14 billionP/E Ratio357.36Consensus RatingModerate BuyConsensus Price Target$6.19 (+73.4% Upside)Volume82.02 million sharesAverage Volume47.63 million shares23. Ovid Therapeutics NASDAQ:OVID$2.27 -0.15 (-6.20%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$2.28 +0.02 (+0.66%) As of 06/18/2026 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$451.67 millionConsensus RatingModerate BuyConsensus Price Target$5.13 (+125.8% Upside)Volume15.35 million sharesAverage Volume1.67 million sharesToday's Range$2.27▼$2.4924. Context Therapeutics NASDAQ:CNTX$0.63 +0.03 (+5.32%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.63 0.00 (-0.46%) As of 06/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$55.13 millionConsensus RatingModerate BuyConsensus Price Target$6.17 (+875.9% Upside)Volume3.08 million sharesAverage Volume2.34 million sharesToday's Range$0.59▼$0.6425. Autolus Therapeutics NASDAQ:AUTL$1.51 -0.02 (-1.31%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.51 +0.00 (+0.13%) As of 06/18/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$407.22 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+479.5% Upside)Volume843,810 sharesAverage Volume1.25 million sharesToday's Range$1.51▼$1.59 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge Jabil Just Gave Investors a Stronger Reason to Buy the Dip USA Rare Earth Just Moved Closer to Commercial Reality After an Initial Panic, Wall Street's Leaning Into Apple's New Siri AI CoreWeave Insider Sales Look Big, But Should Investors Worry? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
